Literature DB >> 6430997

Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.

L K Curtiss, T M Forte, P A Davis.   

Abstract

Lipoproteins were isolated from adult plasma and the umbilical cord blood plasma of newborn infants and were compared for their capacity to inhibit mitogen-stimulated [3H]thymidine uptake of adult peripheral blood mononuclear cells in vitro. Relative to the comparable adult lipoproteins, cord blood low density lipoproteins and high density lipoproteins inhibited mitogen stimulation at twofold to fourfold lower total protein concentrations. Apoproteins AI, B, and E were quantitated by radioimmunoassay of each of the adult and cord blood lipoprotein fractions. A strong correlation was observed between inhibitory activity and the amount of apoprotein E in the cord blood low and high density lipoproteins. Further evidence that lipoproteins containing apoprotein E accounted for the difference in suppressive activity of cord blood low and high density lipoproteins relative to the adult lipoproteins was obtained by selective removal of the apoprotein E-containing lipoproteins by using immunoaffinity chromatography or heparin-agarose adsorption. The results indicated that cord blood lipoproteins containing apoprotein E in association with apoproteins AI or B are capable of suppressing lymphocyte proliferation in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Heterogeneous expression of apolipoprotein-E by human macrophages.

Authors:  Nicodemus Tedla; Elias N Glaros; Ulf T Brunk; Wendy Jessup; Brett Garner
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

2.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

Authors:  K Brand; N Mackman; L K Curtiss
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

3.  Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell.

Authors:  Charlotta Tenger; Xinghua Zhou
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.